Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1053317941
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 219-8777
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.5M
277,538 services
Medicare patients, 2024
1,226
Average age 75
Drug cost, 2024
$13.8M
4,937 prescriptions
Company payments, 2025
$115
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas B Sneed was code J9271 (injection, pembrolizumab, 1 mg), 19,400 times for 23 patients. In total Thomas B Sneed billed 277,538 services in 202 codes, and Medicare paid $4.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,400 | 23 | $43.84 | $850K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 19,200 | 19 | $0.40 | $7,595 |
| J9299 Injection, nivolumab, 1 mg | Office | 15,060 | 13 | $24.63 | $371K |
| J9267 Injection, paclitaxel, 1 mg | Office | 12,121 | 21 | $0.08 | $975 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,510 | 129 | $0.09 | $580 |
| J0185 Injection, aprepitant, 1 mg | Office | 6,500 | 17 | $1.34 | $8,689 |
| J0897 Injection, denosumab, 1 mg | Office | 4,800 | 24 | $19.41 | $93K |
| 85025 Blood Count | Office | 4,137 | 990 | $7.57 | $31K |
| 36415 Venipuncture Blood Collection | Office | 3,995 | 979 | $8.64 | $35K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 3,430 | 11 | $1.42 | $4,855 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 3,190 | 56 | $0.25 | $804 |
| 80053 Clinical Chemistry | Office | 3,040 | 965 | $10.30 | $31K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,040 | 64 | $0.73 | $2,221 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,793 | 30 | $5.69 | $16K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,700 | 25 | $15.67 | $42K |
By year: 2022 $5.9M for 423,213 services; 2023 $4.9M for 320,928 services; 2024 $4.5M for 277,538 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 4,137 | 990 | $7.57 | $31K |
| 36415 Venipuncture Blood Collection | 3,995 | 979 | $8.64 | $35K |
| 80053 Clinical Chemistry | 3,040 | 965 | $10.30 | $31K |
| 82378 Clinical Chemistry | 1,061 | 387 | $18.44 | $20K |
| 86300 Immunoassay | 589 | 249 | $20.30 | $12K |
| 82784 Immunoassay | 588 | 77 | $9.11 | $5,359 |
| 83615 Clinical Chemistry | 558 | 269 | $5.91 | $3,299 |
| 82728 Clinical Chemistry | 423 | 211 | $13.36 | $5,651 |
| 80048 Clinical Chemistry | 359 | 133 | $8.12 | $2,916 |
| 84443 Clinical Chemistry | 338 | 135 | $16.46 | $5,563 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas B Sneed prescribed most often to Medicare patients was Anastrozole, with 453 prescriptions and refills. In total Thomas B Sneed wrote 4,937 Medicare prescriptions that cost $13.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 453 | 853 | 100 | $6,413 |
| Ondansetron Hcl Generic | 275 | 277 | 130 | $3,960 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 231 | 231 | 67 | $6,782 |
| Gabapentin Generic | 180 | 201 | 38 | $2,248 |
| Tamoxifen Citrate Generic | 157 | 245 | 29 | $2,811 |
| Hydroxyurea Generic | 143 | 201 | 22 | $2,031 |
| Levothyroxine Sodium Generic | 133 | 210 | 34 | $885 |
| Calquence Acalabrutinib Maleate | 127 | 127 | 11 | $1.9M |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 117 | 119 | 63 | $1,334 |
| Levofloxacin Generic | 117 | 117 | 75 | $829 |
| Pantoprazole Sodium Generic | 114 | 170 | 39 | $648 |
| Oxycodone Hcl Generic | 97 | 97 | 28 | $1,981 |
| Prochlorperazine Maleate Generic | 90 | 90 | 39 | $1,586 |
| Letrozole Generic | 82 | 100 | 16 | $888 |
| Imbruvica Ibrutinib | 74 | 74 | Under 11 | $1.2M |
Brand drugs: 1,395 claims; generic drugs: 3,542 claims; opioid claims: 523.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas B Sneed $115 ($115 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.